Brief: Biosyent Announces Normal Course Issuer Bid
04/12/2018 13:58
Dec 4 (Reuters) - Biosyent Inc RX.V :
* BIOSYENT ANNOUNCES NORMAL COURSE ISSUER BID
* BIOSYENT INC - MAY PURCHASE FOR CANCELLATION UP TO 950,000
OF
ITS COMMON SHARES OVER A 12-MONTH PERIOD
Source text for Eikon: ID:nGNX19JHcy
Further company coverage: RX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid